Ermakov E, Melamud M, Boiko A, Kamaeva D, Ivanova S, Nevinsky G
Brain Sci. 2023; 13(5).
PMID: 37239308
PMC: 10216189.
DOI: 10.3390/brainsci13050836.
Luis J, Simoes C, Brito R
Int J Mol Sci. 2022; 23(3).
PMID: 35163653
PMC: 8915186.
DOI: 10.3390/ijms23031731.
Reale M, Costantini E, Greig N
Front Psychiatry. 2021; 12:536257.
PMID: 33746786
PMC: 7973221.
DOI: 10.3389/fpsyt.2021.536257.
Kogan S, Ospina L, Mittal V, Kimhy D
Eur Arch Psychiatry Clin Neurosci. 2019; 270(7):793-802.
PMID: 31620871
PMC: 7160015.
DOI: 10.1007/s00406-019-01073-2.
Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho A
Mol Neurobiol. 2019; 57(2):778-797.
PMID: 31473906
DOI: 10.1007/s12035-019-01737-z.
The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies.
Pozzi D, Menna E, Canzi A, Desiato G, Mantovani C, Matteoli M
Front Mol Neurosci. 2018; 11:111.
PMID: 29674955
PMC: 5895746.
DOI: 10.3389/fnmol.2018.00111.
Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?.
Borovcanin M, Jovanovic I, Radosavljevic G, Pantic J, Minic Janicijevic S, Arsenijevic N
Front Psychiatry. 2017; 8:221.
PMID: 29163240
PMC: 5681495.
DOI: 10.3389/fpsyt.2017.00221.
A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue.
van den Oord E, Clark S, Xie L, Shabalin A, Dozmorov M, Kumar G
Schizophr Bull. 2015; 42(4):1018-26.
PMID: 26656881
PMC: 4903046.
DOI: 10.1093/schbul/sbv182.
Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume.
Fillman S, Weickert T, Lenroot R, Catts S, Bruggemann J, Catts V
Mol Psychiatry. 2015; 21(8):1090-8.
PMID: 26194183
PMC: 4960447.
DOI: 10.1038/mp.2015.90.
Cryoglobulins as potential triggers of inflammation in schizophrenia.
Chavushyan A, Hovsepyan M, Boyajyan A
Schizophr Res Treatment. 2014; 2013:125264.
PMID: 24455252
PMC: 3876917.
DOI: 10.1155/2013/125264.
Genome-wide association study of treatment refractory schizophrenia in Han Chinese.
Liou Y, Wang H, Lee M, Wang S, Chiang H, Chen C
PLoS One. 2012; 7(3):e33598.
PMID: 22479419
PMC: 3313922.
DOI: 10.1371/journal.pone.0033598.
Inflammatory biomarkers and depression.
Muller N, Myint A, Schwarz M
Neurotox Res. 2010; 19(2):308-18.
PMID: 20658274
DOI: 10.1007/s12640-010-9210-2.
[Correlations between risk gene variants for schizophrenia and brain structure anomalies].
Nickl-Jockschat T, Rietschel M, Kircher T
Nervenarzt. 2008; 80(1):40-2, 44-6, 48 passim.
PMID: 18820892
DOI: 10.1007/s00115-008-2576-1.
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication.
Schmitt A, Bertsch T, Tost H, Bergmann A, Henning U, Klimke A
Neuropsychiatr Dis Treat. 2008; 1(2):171-7.
PMID: 18568063
PMC: 2413198.
DOI: 10.2147/nedt.1.2.171.61048.
[Immunological aspects of depressive disorders].
Muller N, Schwarz M
Nervenarzt. 2007; 78(11):1261-73.
PMID: 17928982
DOI: 10.1007/s00115-007-2311-3.
Interleukin-1 beta gene polymorphism and its interactions with neuregulin-1 gene polymorphism are associated with schizophrenia.
Hanninen K, Katila H, Saarela M, Rontu R, Mattila K, Fan M
Eur Arch Psychiatry Clin Neurosci. 2007; 258(1):10-5.
PMID: 17901998
DOI: 10.1007/s00406-007-0756-9.
Effects of Toxoplasma gondii infection on the brain.
Carruthers V, Suzuki Y
Schizophr Bull. 2007; 33(3):745-51.
PMID: 17322557
PMC: 2526127.
DOI: 10.1093/schbul/sbm008.
[Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].
Schuld A, Hinze-Selch D, Pollmacher T
Nervenarzt. 2004; 75(3):215-26.
PMID: 15021922
DOI: 10.1007/s00115-003-1599-x.
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
Frommberger U, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M
Eur Arch Psychiatry Clin Neurosci. 1997; 247(4):228-33.
PMID: 9332905
DOI: 10.1007/BF02900219.